Colorectal polyps: the scope and management of the problem.
Colorectal cancer affects over 150,000 individuals yearly, and accounts for over 50,000 deaths. Much of the benefit of colorectal cancer screening has been attributed to detection and removal of adenomatous polyps, highlighting the importance of colorectal polyps as targets for intervention and as biomarkers for colorectal cancer risk. This review details the epidemiology of sporadic colorectal polyps, rationale behind use of polyps as an important surrogate for colorectal cancer risk, the benefits and limitations of secondary prevention of colorectal polyps through chemopreventive and dietary interventions, as well as colon surveillance.
Gupta
Samir
S
Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8887, USA. samir.gupta@utsouthwestern.edu
D000236:Adenoma / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control; D003111:Colonic Polyps / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology / Q000601:surgery*; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D003226:Congresses as Topic; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004032:Diet; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D012307:Risk Factors; D012812:Sigmoidoscopy
D016861:Cyclooxygenase Inhibitors